C.R. Leemans
Papers
1
Total Citations
2
H-Index
1
About
C.R. Leemans is a leading figure in head and neck oncology, with a clinical and research focus on optimizing treatment strategies for oropharyngeal, supraglottic, and hypopharyngeal carcinomas. Their major contribution lies in pioneering comparative effectiveness research that directly challenges the conventional treatment paradigm for early-stage cancers. Leemans designed and leads the landmark Phase III study (706TiP), which rigorously compares the "best of" radiotherapy against the "best of" trans-oral surgery (TOS) in patients with T1-T2, N0-N1 tumors. This work is critical for evidence-based decision-making, aiming to clarify which modality offers superior oncologic outcomes and quality of life. While the study has garnered 2 citations to date, its significance is profound as it addresses a long-standing clinical equipoise. Leemans’ research is instrumental in shaping future guidelines, reducing treatment morbidity, and personalizing care for patients with head and neck cancers, marking them as a key contributor to the evolution of minimally invasive and radiation-sparing approaches.
Research Focus
Key Achievements
Top Papers
- 1